Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes

Thrombosis and Haemostasis

Volumn 86, Issue 4, 2001, Pages 1094-1098

  Huang, Y Q ^a   Li, J J ^a   Hu, L ^a   Lee, M ^a   Karpatkin, S ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

Angiogenesis; PI3Kinase; Serine threonine kinase; Thrombin; VEGF

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACTINOMYCIN DERIVATIVE; HIRUDIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE THREONINE KINASE; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; VASCULOTROPIN; WORTMANNIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; DRUG INHIBITION; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MEGAKARYOCYTE; METASTASIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION; TUMOR GROWTH; VASCULAR ENDOTHELIUM;

EID: 0034763273     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616538     Document Type: Article

References (57)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Angiogenesis
3. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
4. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate
5. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis
6. Interleukin 6 induces the expression of vascular endothelial growth factor
7. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing
8. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology
9. Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells
10. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells
11. Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma
12. Hypoxia-induced vascular endothelial growth factor expression in normal rat astrocyte cultures. Hypoxia-induced vascular endothelial growth factor expression in normal rat astrocyte cultures
13. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element
14. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein
15. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1
16. Isolation of angiopoietin-1, a ligand for the TIE-2 receptor, by secretion-trap expression cloning
17. Requisite role of angiopoietin-1, a ligand for the TIE-2 receptor, during embryonic angiogenesis
18. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
19. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis
20. Angiopoietin-1 induces sprouting angiogenesis in vitro
21. Hypoxia and vascular endothelial growth factor selectively up-regulate Angiopoietin-2 in bovine microvascular endothelial cells
22. Thrombin promotes endothelial cell alignment in matrigel in vitro and angiogenesis in vivo
23. Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway
24. On the endothelial growth factor activity on endothelial cells by up-regulation of its receptors
25. Thrombin promotes angiogenesis by a mechanism independent of fibrin formation
26. Isolation of fibrinogen-fibrin related antigen from human plasma by immune-affinity chromatography: Its characterization in normal subjects and in defibrinating patients with abruptio placentae and disseminated cancer
27. Significance of plasma fibrinopeptide A (FPA) in patients with malignancy
28. Abnormalities of blood coagulation in patients with cancer: Fibrinopeptide A generation and tumor growth
29. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease
30. Thrombin stimulates melanoma tumor cell binding to endothelial cells and subendothelial matrix
31. Presence of the seven transmembrane thrombin receptor on human tumour cells: Effect of activation on tumour adhesion to platelets and tumour tyrosine phosphorylation
32. Protease-Activated Receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis
33. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and metastasis in vivo
34. Cellular consequences of thrombin-receptor activation
35. Thrombin induces the release of angiopoietin-1 from platelets
36. Constitutive production and thrombin-induced release of vascular endothelial growth factor by megakaryocytes and platelets
37. In vitro release of VEGF during platelet aggregation
38. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
39. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
40. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
41. Cellular localization of enzymatically-active thrombin in intact tissue by hirudin binding
42. Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumour growth in vivo
43. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody
44. Thrombin receptor overexpression in malignant and physiological invasion processes
45. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo
46. Effect of anti-platelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma and B16 amelanotic melanoma tumor cells in mice
47. Thrombin induces the synthesis of VEGF and Angiopoietin-2 (Ang-2)
48. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa
49. Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells
50. Hypoxia-inducible transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor
51. Phosphatidylinositol 3,4,5-trisphosphate is formed from phosphatidylinositol 4,5-bisphosphate in thrombin-stimulated platelets
52. Thrombin-dependent association of phosphatidylinositol-3 kinase with p60c-src and p59fyn in human platelets
53. Differential translocation of protein kinase C isozymes by thrombin and platelet-derived growth factor. A possible function for phosphatidylchline-derived diacylglycerol
54. Alpha-thrombin stimulates nuclear diglyceride levels and differential nuclear localization of protein kinase C isozymes in IIC9 cells
55. Regulation of vascular endothelial growth factor in cardiac myocytes
56. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells